Related Experiment Video
Updated: Feb 22, 2026
04:22
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
974
Laparoscopic liver resection for metastatic melanoma
Davit L Aghayan1,2, Airazat M Kazaryan3,4, Åsmund Avdem Fretland3,5,6
1The Intervention Centre, Oslo University Hospital - Rikshospitalet, Pb. 4950 Nydalen, 0424, Oslo, Norway. dr.aghayan@gmail.com.
Surgical Endoscopy
|September 17, 2017
Summary
Laparoscopic liver resection (LLR) for melanoma liver metastasis (MLM) shows promising results. This minimally invasive approach offers comparable outcomes to open surgery, with potential benefits for patient recovery and future treatments.
Area of Science:
- Surgical Oncology
- Hepatobiliary Surgery
- Minimally Invasive Surgery
Background:
- Stage IV metastatic melanoma has a poor prognosis.
- Melanoma liver metastasis (MLM) can be treated with surgical resection.
- Laparoscopic liver resection (LLR) for MLM is not well-studied.
Purpose of the Study:
- To analyze the outcomes of laparoscopic liver resection (LLR) in patients with melanoma liver metastasis (MLM).
Main Methods:
- Retrospective analysis of 11 patients undergoing 13 LLR procedures for MLM between 2000 and 2013.
- Evaluation of perioperative and oncologic outcomes, including morbidity (Accordion classification) and survival (Kaplan-Meier).
Main Results:
- Median operative time: 137 minutes; median blood loss: <50 ml.
- No intraoperative incidents or 30-day mortality.
- Median follow-up: 33 months; 91% recurrence rate within 5 months.
- 1-, 3-, and 5-year overall survival rates: 82%, 45%, and 9% respectively.
Conclusions:
- LLR for MLM demonstrates perioperative morbidity and long-term survival comparable to open liver resection.
- LLR may be preferable to open resection due to laparoscopic advantages like reduced pain and potential for repeat resections.
